Pharmacokinetics of the phosphatidylserine tracers 99mTc-lactadherin and 99mTc-annexin V in pigs

EJNMMI Research

Volumn 3, Issue 1, 2013, Pages 1-9

  Poulsen, Runa H ^a   Rasmussen, Jan T ^b   Ejlersen, June Anita ^c   Flø, Christian ^a   Falborg, Lise ^a   Heegaard, Christian W ^b   Rehling, Michael ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c REGIONAL HOSPITAL WEST JUTLAND   (Denmark)

Author keywords

Annexin v; Clearance; Distribution; Dosimetry; Kinetics; Lactadherin; Phosphatidylserine

Indexed keywords

CHROMIUM 51; EDETIC ACID; LACTADHERIN; LIPOCORTIN 5; PHOSPHATIDYLSERINE; TECHNETIUM 99M;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; DOSIMETRY; EXPERIMENTAL PIG; FEMALE; IN VIVO STUDY; ISOTOPE LABELING; KIDNEY CLEARANCE; KIDNEY PERFUSION; KIDNEY VEIN; LIVER PARENCHYMA; MALE; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; RENAL ARTERY; TISSUE DISTRIBUTION; URINE FLOW RATE;

EID: 84876859123     PISSN: None     EISSN: 2191219X     Source Type: Journal    
DOI: 10.1186/2191-219X-3-15     Document Type: Article

References (31)

1. Krysko O, De RL, Cornelissen M: Phosphatidylserine exposure during early primary necrosis (oncosis) in JB6 cells as evidenced by immunogold labeling technique. Apoptosis 2004, 9:495-500.
2. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM: Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 1992, 148:2207-2216.
3. Balasubramanian K, Mirnikjoo B, Schroit AJ: Regulated externalization of phosphatidylserine at the cell surface: implications for apoptosis. J Biol Chem 2007, 282:18357-18364.
4. Kenis H, Zandbergen HR, Hofstra L, Petrov AD, Dumont EA, Blankenberg FD, Haider N, Bitsch N, Gijbels M, Verjans JW, Narula N, Narula J, Reutelingsperger CP: Annexin A5 uptake in ischemic myocardium: demonstration of reversible phosphatidylserine externalization and feasibility of radionuclide imaging. J Nucl Med 2010, 51:259-267.
5. Mari C, Karabiyikoglu M, Goris ML, Tait JF, Yenari MA, Blankenberg FG: Detection of focal hypoxic-ischemic injury and neuronal stress in a rodent model of unilateral MCA occlusion/reperfusion using radiolabeled annexin V. Eur J Nucl Med Mol Imaging 2004, 31:733-739.
6. Blankenberg FG: Imaging the molecular signatures of apoptosis and injury with radiolabeled annexin V. Proc Am Thorac Soc 2009, 6:469-476.
7. Taki J, Higuchi T, Kawashima A, Fukuoka M, Kayano D, Tait JF, Matsunari I, Nakajima K, Kinuya S, Strauss HW: Effect of postconditioning on myocardial 99mTc-annexin-V uptake: comparison with ischemic preconditioning and caspase inhibitor treatment. J Nucl Med 2007, 48:1301-1307.
8. Narula J, Strauss HW: Invited commentary: P.S.* I love you: implications of phosphatidyl serine (PS) reversal in acute ischemic syndromes. J Nucl Med 2003, 44:397-399.
9. Rottey S, Slegers G, Van BS, Goethals I, Van de WC: Sequential 99mTc-hydrazinonicotinamide-annexin V imaging for predicting response to chemotherapy. J Nucl Med 2006, 47:1813-1818.
10. Vangestel C, Van de Wiele C, Van Damme N, Staelens S, Pauwels P, Reutelingsperger CP, Peeters M: (99)mTc-(CO)(3) His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab. J Nucl Med 2011, 52:1786-1794.
11. Shi J, Pipe SW, Rasmussen JT, Heegaard CW, Gilbert GE: Lactadherin blocks thrombosis and hemostasis in vivo: correlation with platelet phosphatidylserine exposure. J Thromb Haemost 2008, 6:1167-1174.
12. Dasgupta SK, Guchhait P, Thiagarajan P: Lactadherin binding and phosphatidylserine expression on cell surface-comparison with annexin A5. Transl Res 2006, 148:19-25.
13. Waehrens LN, Rasmussen JT, Heegaard CW, Faldborg L: Preparation and in vitro evaluation of 99 m-Tc-labelled bovine lactadherin as a novel radioligand for apoptosis detection. J Label Compd Radiopham 2007, 50:211-217.
14. Smith C, Gibson DF, Tait JF: Transmembrane voltage regulates binding of annexin V and lactadherin to cells with exposed phosphatidylserine. BMC Biochem 2009, 10:5.
15. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S: Identification of a factor that links apoptotic cells to phagocytes. Nature 2002, 417:182-187.
16. Toda S, Hanayama R, Nagata S: Two-step engulfment of apoptotic cells. Mol Cell Biol 2012, 32:118-125.
17. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I: Immunosuppressive effects of apoptotic cells. Nature 1997, 390:350-351.
18. Hanayama R, Tanaka M, Miyasaka K, Aozasa K, Koike M, Uchiyama Y, Nagata S: Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 2004, 304:1147-1150.
19. Cui T, Miksa M, Wu R, Komura H, Zhou M, Dong W, Wang Z, Higuchi S, Chaung W, Blau SA, Marini CP, Ravikumar TS, Wang P: Milk fat globule epidermal growth factor 8 attenuates acute lung injury in mice after intestinal ischemia and reperfusion. Am J Respir Crit Care Med 2010, 181:238-246.
20. Cheyuo C, Jacob A, Wu R, Zhou M, Qi L, Dong W, Ji Y, Chaung WW, Wang H, Nicastro J, Coppa GF, Wang P: Recombinant human MFG-E8 attenuates cerebral ischemic injury: Its role in anti-inflammation and anti-apoptosis. Neuropharmacology 2012, 62:890-900.
21. Falborg L, Waehrens LN, Alsner J, Bluhme H, Frokiaer J, Heegaard CW, Horsman MR, Rasmussen JT, Rehling M: Biodistribution of 99mTc-HYNIC-lactadherin in mice-a potential tracer for visualizing apoptosis in vivo. Scand J Clin Lab Invest 2010, 70:209-216.
22. Kartachova M, Haas RL, Olmos RA, Hoebers FJ, van Zandwijk N, Verheij M: In vivo imaging of apoptosis by 99mTc-annexin V scintigraphy: visual analysis in relation to treatment response. Radiother Oncol 2004, 72:333-339.
23. Kartachova M, an Zandwijk N, Burgers S, van Tinteren H, Verheij M, Valdes Olmos RA: Prognostic significance of 99mTc Hynic-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancer. J Clin Oncol 2007, 25:2534-2539.
24. Hoebers FJ, Kartachova M, de Bois J, van den Brekel MW, van Tinteren H, van Herk M, Rasch CRN, Valdés Olmos RA, Verheij M: 99mTc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy. Eur J Nucl Med Mol Imaging 2008, 35:509-518.
25. Kemerink GJ, Liu X, Kieffer D, Ceyssens S, Mortelmans L, Verbruggen AM, Steinmetz ND, Vanderheyden JL, Green AM, Verbeke K: Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application. J Nucl Med 2003, 44:947-952.
26. Tait JF, Smith C, Blankenberg FG: Structural requirements for in vivo detection of cell death with 99mTc-annexin V. J Nucl Med 2005, 46:807-815.
27. Aziz M, Jacob A, Matsuda A, Wang P: Review: milk fat globule-EGF factor 8 expression, function and plausible signal transduction in resolving inflammation. Apoptosis 2011, 16:1077-1086.
28. Bu HF, Zuo XL, Wang X, Ensslin MA, Koti V, Hsueh W, Raymond AS, Shur BD, Tan XD: Milk fat globule-EGF factor 8/lactadherin plays a crucial role in maintenance and repair of murine intestinal epithelium. J Clin Invest 2007, 117:3673-3683.
29. Hirt UA, Leist M: Rapid, noninflammatory and PS-dependent phagocytic clearance of necrotic cells. Cell Death Differ 2003, 10:1156-1164.
30. Otzen DE, Andersen KK: Folding of outer membrane proteins. Arch Biochem Biophys 2012,:. doi:10.1016/j.abb.2012.10.008
31. Dini L, Pagliara P, Carla EC: Phagocytosis of apoptotic cells by liver: a morphological study. Microsc Res Tech 2002, 57:530-540.